PharmaShots Weekly Snapshots (December 25 – December 29, 2023)
This week PharmaShots’ news was all about the updates on M&A, Pharma, Clinical Trials, Regulatory & MedTech. Check out our full report below:
For an Aggregate of ~$14B, BMS Acquires Karuna Therapeutics
Read More: BMS & Karuna Therapeutics
For an Aggregate of ~$1.2B, AstraZeneca to Acquire Gracel Biotechnology
Read More: AstraZeneca & Gracel Biotechnology
For an Aggregate of ~$4.1B, BMS to Acquire RayzeBio
Read More: BMS & RayzeBio
Crossject Enters into a Collaboration Agreement with its Strategic Partner to Commercialize Zepizure Across Europe for Epileptic Seizures
Read More: Crossject
For an Aggregate of ~$70M, Polaris Group Acquires Genovior Biotech
Read More: Polaris Group & Genovior Biotech
LegoChem Signs a Collaboration Agreement with Janssen Biotech to Develop and Commercialize LCB84 Trop2-Targeted ADC
Read More: LegoChem & Janssen Biotech
Innovent Signs a Collaboration Agreement with SanegeneBio to Develop SGB-3908 for the Treatment of Hypertension
Read More: Innovent & SanegeneBio
Innovent Biologics Sings a Collaboration Agreement with Xuanzhu Biopharma to Study and Supply Tyvyt with KM-501 for Solid Tumors
Read More: Innovent Biologics & Xuanzhu Biopharma
Codexis and Nestlé Health Science Collaborate to Develop CDX-7108 for Treating Exocrine Pancreatic Insufficiency (EPI)
Read More: Codexis & Nestlé Health Science
Astellas Sings Research Collaboration and License Agreement with Elpiscience to Develop Bispecific Macrophage Engagers to Treat Cancer
Read More: Astellas & Elpiscience
Hi-Tech Pharmaceuticals Reports Launch of Slimaglutide
Read More: Hi-Tech Pharmaceuticals
Tyra Biosciences Highlights the Clinical Trial Updates for TYRA-200 and TYRA-300 to Treat Solid Tumors
Read More: Tyra Biosciences
Amylyx Pharmaceuticals Reports the First Patient Dosing in P-III Trial of AMX0035 to Treat Progressive Supranuclear Palsy (PSP)
Read More: Amylyx Pharmaceuticals
Merck and Daiichi Sankyo Reports the US FDA’s Acceptance of BLA for HER3-DXd and Receives Priority Review for the Treatment of Non Small Cell Lung Cancer
Read More: Merck and Daiichi Sankyo
Hyloris Highlights the Clinical Data for Valacyclovir Oral Suspension to Treat Herpes Virus Infections
Read More: Hyloris
Kuros Biosciences Highlights the Results from Two Clinical Trials in Patients with Degenerative Disc Disease (DDD)
Read More: Kuros Biosciences
Cytokinetics Reveals P-III (SEQUOIA-HCM) Study Results of Aficamten for Obstructive Hypertrophic Cardiomyopathy
Read More: Cytokinetics
Jiangsu Recbio Technology Reports Interim Analysis Data from the Study of REC610 for Shingles Conducted in the Philippines
Read More: Jiangsu Recbio Technology
NKGen Biotech Reports First Patient Dosing with SNK01 in P-I/IIa Study for Treating Moderate Alzheimer’s Disease
Read More: NKGen Biotech
Boston Scientific Commences (AVANT GUARD) Study of Farapulse Pulsed Field Ablation System as a 1L Treatment for Persistent Atrial Fibrillation (AF)
Read More: Boston Scientific
BeiGene Receives the US FDA’s Approval to Update Label for Brukinsa to Include Chronic Lymphocytic Leukemia
Read More: BeiGene
Zealand Pharma Reports NDA Submission for Glepaglutide to the US FDA for the Treatment of Short Bowel Syndrome (SBS)
Read More: Zealand Pharma
The US FDA Cleared Senti Bio’s IND Application for SENTI-202 to Treat Hematologic Malignancies
Read More: Senti Bio
The EMA Approves Cidara Therapeutics’ Rezzayo for the Treatment of Invasive Candidiasis
Read More: Cidara Therapeutics
The TGA Approve Asieris’ Application to Initiate P-I Trial APL-2301 to Treat Acinetobacter baumannii Infection
Read More: Asieris
The US FDA Approves CVRx’s Label Expansion for Barostim
Read More: CVRx
The Taiwan FDA Accepts Everest Medicines’ NDA for Nefecon to Treat Primary IgA Nephropathy
Read More: Everest Medicines
Sequana Medical Submits a Premarket Approval Application to the US FDA for alfapump to Treat Ascites due to Liver Cirrhosis
Read More: Sequana Medical
CytoSorbents Reports Initial Data Analysis from the STAR-T Study of DrugSorb-ATR to Reduce Perioperative Bleeding
Read More: CytoSorbents
Vivesto Reports Approval of the US Clinical Paccal Vet Study in Dogs with Splenic Hemangiosarcoma
Read More: Vivesto
Related Post:- PharmaShots Weekly Snapshots (December 18 – December 22, 2023)
Tags
Shivani was a content writer at PharmaShots. She has a keen interest in recent innovations in the life sciences industry. She was covering news related to Product approvals, clinical trial results, and updates. We can be contacted at connect@pharmashots.com.
